Display options
Share it on

BMJ Open. 2013 Jan 31;3(2). doi: 10.1136/bmjopen-2012-001887. Print 2013.

Intrapleural fibrinolytic therapy (IPFT) in loculated pleural effusions--analysis of predictors for failure of therapy and bleeding: a cohort study.

BMJ open

Saleh Abu-Daff, Donna E Maziak, Derar Alshehab, Jennifer Threader, Jelena Ivanovic, Valerie Deslaurier, Patrick-James Villeneuve, Sebastian Gilbert, Sudhir Sundaresan, Farid Shamji, Colleen Lougheed, Jean M Seely, Andrew J E Seely

Affiliations

  1. Division of Thoracic Surgery, Department of Surgery, University of Ottawa and the Ottawa Hospital, Ottawa, Canada.

PMID: 23377992 PMCID: PMC3586180 DOI: 10.1136/bmjopen-2012-001887

Abstract

OBJECTIVES: To assess risk factors associated with failure and bleeding in intrapleural fibrinolytic therapy (IPFT) for pleural effusions.

DESIGN: Retrospective case series.

SETTING: Two tertiary-care centres in North America.

PARTICIPANTS: We identified 237 cases that received IPFT for the treatment of pleural effusions. Data for 227 patients were compiled including demographics, investigations, radiological findings pretherapy and post-therapy and outcomes.

INTERVENTION: Fibrinolytic therapy in the form of tissue plasminogen activator (t-PA) or streptokinase.

PRIMARY AND SECONDARY OUTCOMES: Success of therapy is defined as the presence of both clinical and radiological improvement leading to resolution. Failure was defined as persistence (ie, ineffective treatment) or complications requiring intervention from IPFT. Incidence of bleeding post-IPFT, identifying factors related to failure of therapy and bleeding.

RESULTS: IPFT was used in 237 patients with pleural effusions; 163 with empyema/complicated parapneumonic effusions, 32 malignant effusions and 23 with haemothorax. Overall, resolution was achieved in 80% of our cases. Failure occurred in 46 (20%) cases. Multivariate analysis revealed that failure was associated with the presence of pleural thickening (>2 mm) on CT scan (p=0.0031, OR 3, 95% CI 1.46 to 6.57). Bleeding was not associated with any specific variable in our study (antiplatelet medications, p=0.08).

CONCLUSIONS: Pleural thickening on a CT scan was found to be associated with failure of IPFT.

References

  1. Respir Med. 2008 Dec;102(12):1694-700 - PubMed
  2. Am J Respir Crit Care Med. 1999 Jan;159(1):37-42 - PubMed
  3. Thorax. 2002 Apr;57(4):343-7 - PubMed
  4. J Trauma. 2004 Dec;57(6):1178-83 - PubMed
  5. N Engl J Med. 2005 Mar 3;352(9):865-74 - PubMed
  6. N Engl J Med. 2011 Aug 11;365(6):518-26 - PubMed
  7. Arch Surg. 2000 Aug;135(8):907-12 - PubMed
  8. Thorax. 1997 May;52(5):416-21 - PubMed
  9. Am Rev Respir Dis. 1993 Apr;147(4):962-6 - PubMed
  10. Scand J Thorac Cardiovasc Surg. 1977;11(3):265-8 - PubMed
  11. Am J Ther. 2007 Jul-Aug;14(4):341-5 - PubMed
  12. Am J Respir Crit Care Med. 2004 Jul 1;170(1):49-53 - PubMed
  13. Chest. 2001 May;119(5):1547-62 - PubMed
  14. Chest. 1978 Aug;74(2):170-3 - PubMed
  15. Am J Respir Crit Care Med. 1997 Jan;155(1):291-5 - PubMed
  16. J Clin Invest. 1949 Jan;28(1):173-90 - PubMed
  17. Chest. 2003 Apr;123(4):1188-95 - PubMed

Publication Types